Tomas D. Bertmark
Direttore/Membro del Consiglio presso CanImGuide Therapeutics AB
Posizioni attive di Tomas D. Bertmark
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Direttore/Membro del Consiglio | - | - |
| Corporate Officer/Principal | - | - |
Storia della carriera di Tomas D. Bertmark
Statistiche
Distribuzione geografica
| Svezia | 2 |
Posizioni
| Director/Board Member | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Health Technology |
- Borsa valori
- Insiders
- Tomas D. Bertmark
- Esperienza
